Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Cohort Study on the Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis After Treatment for Primary Visceral Leishmaniasis in South Sudan

NCT05449717 is registered in ClinicalTrials.gov with Epicentre as lead sponsor.

NCT NCT05449717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05449717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Cohort Study on the Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis After Treatment for Primary Visceral Leishmaniasis in South Sudan
Lead sponsor
Epicentre
Phase
Observational
Overall status
Completed
Start date
May 31, 2022
Completion date
April 11, 2025
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leishmaniasis, leishmaniasis, visceral, post-kala-azar dermal leishmaniasis